Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 1 2Phase NA 1Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1

Conditions

Vomiting 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Multiple Myeloma 8Neoplasms 7Nausea 7Leukemia 7Lymphoma, Non-Hodgkin 5Lymphoma 5Immunoglobulin Light-chain Amyloidosis 4Breast Neoplasms 4Polycystic Ovary Syndrome 3Lymphoma, Follicular 3Testicular Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Sezary Syndrome 2Sarcoma 2Prostatic Neoplasms 2Primary Myelofibrosis 2Postoperative Nausea and Vomiting 2Pdgfra-Associated Chronic Eosinophilic Leukemia 2Ovarian Neoplasms 2Obesity 2Neuroblastoma 2Myeloproliferative Disorders 2Myelodysplastic Syndromes 2Mycosis Fungoides 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2

Interventions

fludarabine phosphate 2fludarabine 2Whole-Body Irradiation 1Melphalan 1Maintenance 1High-Throughput Screening Assays 1Dexamethasone 1Cyclosporine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Leukemia, Plasma Cell × Dexamethasone × Clear all
NCT04008888 2019-07-05

a Clinical Trial of Efficacy and Safety of the Holistic Treatment of Young High-risk Multiple Myeloma Patients

Institute of Hematology & Blood Diseases Hospital, China

Phase NA Unknown
50 enrolled
Other hematologic neoplasmPlasma cell

Chromosome 17 deletion, Leukemia, Plasma Cell, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡